Gossamer Bio, Inc. (GOSS) return on equity (ROE)

Return on equity · fiscal 2024
-191.7%

Gossamer Bio, Inc. (GOSS) earned a return on equity of -191.7% in fiscal 2024 (the year ended December 31, 2024). That is 94.8 percentage points higher than the -286.5% of fiscal 2023. Figures as of 17 Nov 2026, 19:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2024
-191.7%
Change on fiscal 2023
+94.8 pts
Highest on record
-51.2%fiscal 2019
Lowest on record
-1899.3%fiscal 2022
Fiscal years on record
62019–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Gossamer Bio, Inc. return on equity (ROE), in more detail

Across the 6 fiscal years on record (2019–2024), the highest was -51.2% in fiscal 2019 and the lowest -1899.3% in fiscal 2022. The fiscal 2024 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -192.7%.

History · 6 fiscal years

Return on equity by fiscal year

Gossamer Bio, Inc. return on equity (ROE), year by year

Gossamer Bio, Inc. (GOSS) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2024-191.7% 94.8 pts up
2023-286.5% 1612.8 pts up
2022-1899.3% 1706.6 pts down
2021-192.7% 116.8 pts down
2020-75.9% 24.7 pts down
2019-51.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on GOSS

Gossamer Bio, Inc., figure by figure

Gossamer Bio, Inc. (GOSS) overview: price, valuation and scorecard

Gossamer Bio, Inc. return on equity (ROE): questions and answers

What is Gossamer Bio, Inc.'s return on equity?

Gossamer Bio, Inc. (GOSS) earned a return on equity of -191.7% in fiscal 2024 (the year ended December 31, 2024). That is 94.8 percentage points higher than the -286.5% of fiscal 2023.

Is Gossamer Bio, Inc.'s return on equity high or low compared with its own history?

The fiscal 2024 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -192.7%.

What are the highest and lowest return on equity figures on record for Gossamer Bio, Inc.?

Across the 6 fiscal years on record (2019–2024), the highest was -51.2% in fiscal 2019 and the lowest -1899.3% in fiscal 2022.

How is Gossamer Bio, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gossamer Bio, Inc. (GOSS) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/GOSS/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.